These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 32096034)

  • 21. Syntaxins 6 and 8 facilitate tau into secretory pathways.
    Lee WS; Tan DC; Deng Y; van Hummel A; Ippati S; Stevens C; Carmona-Mora P; Ariawan D; Hou L; Stefen H; Tomanic T; Bi M; Tomasetig F; Martin A; Fath T; Palmer S; Ke YD; Ittner LM
    Biochem J; 2021 Apr; 478(7):1471-1484. PubMed ID: 33769438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the endolysosomal pathway and exosome release in tau propagation.
    Yan M; Zheng T
    Neurochem Int; 2021 May; 145():104988. PubMed ID: 33582164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intersection of pathological tau and microglia at the synapse.
    Vogels T; Murgoci AN; Hromádka T
    Acta Neuropathol Commun; 2019 Jul; 7(1):109. PubMed ID: 31277708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Mechanisms in the Pathogenesis of Alzheimer's disease and Tauopathies-Prion-Like Seeded Aggregation and Phosphorylation.
    Hasegawa M
    Biomolecules; 2016 Apr; 6(2):. PubMed ID: 27136595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Brain insulin signaling and Tau: impact for Alzheimer's disease and Tauopathies].
    Joly-Amado A; Gratuze M; Benderradji H; Vieau D; Buée L; Blum D
    Med Sci (Paris); 2018 Nov; 34(11):929-935. PubMed ID: 30526837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fate and propagation of endogenously formed Tau aggregates in neuronal cells.
    Chastagner P; Loria F; Vargas JY; Tois J; I Diamond M; Okafo G; Brou C; Zurzolo C
    EMBO Mol Med; 2020 Dec; 12(12):e12025. PubMed ID: 33179866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glial contributions to neurodegeneration in tauopathies.
    Leyns CEG; Holtzman DM
    Mol Neurodegener; 2017 Jun; 12(1):50. PubMed ID: 28662669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prion-like Spreading in Tauopathies.
    Ayers JI; Giasson BI; Borchelt DR
    Biol Psychiatry; 2018 Feb; 83(4):337-346. PubMed ID: 28506438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).
    Gibbons GS; Kim SJ; Robinson JL; Changolkar L; Irwin DJ; Shaw LM; Lee VM; Trojanowski JQ
    Acta Neuropathol Commun; 2019 Mar; 7(1):34. PubMed ID: 30832741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-terminal tau truncation in the pathogenesis of Alzheimer's disease (AD): Developing a novel diagnostic and therapeutic approach.
    Amadoro G; Latina V; Corsetti V; Calissano P
    Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165584. PubMed ID: 31676377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tau and tauopathies.
    Robert M; Mathuranath PS
    Neurol India; 2007; 55(1):11-6. PubMed ID: 17272893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
    Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY
    J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Astrocytic uptake of neuronal corpses promotes cell-to-cell spreading of tau pathology.
    Mothes T; Portal B; Konstantinidis E; Eltom K; Libard S; Streubel-Gallasch L; Ingelsson M; Rostami J; Lindskog M; Erlandsson A
    Acta Neuropathol Commun; 2023 Jun; 11(1):97. PubMed ID: 37330529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synaptic Contacts Enhance Cell-to-Cell Tau Pathology Propagation.
    Calafate S; Buist A; Miskiewicz K; Vijayan V; Daneels G; de Strooper B; de Wit J; Verstreken P; Moechars D
    Cell Rep; 2015 May; 11(8):1176-83. PubMed ID: 25981034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neuropathology of tauopathy].
    Yoshida M
    Brain Nerve; 2013 Dec; 65(12):1445-58. PubMed ID: 24323931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synaptic Localisation of Tau.
    Hanger DP; Goniotaki D; Noble W
    Adv Exp Med Biol; 2019; 1184():105-112. PubMed ID: 32096032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
    Lewis J; Dickson DW
    Acta Neuropathol; 2016 Jan; 131(1):27-48. PubMed ID: 26576562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Focusing on oligomeric tau as a therapeutic target in Alzheimer's disease and other tauopathies.
    Rayman JB
    Expert Opin Ther Targets; 2023; 27(4-5):269-279. PubMed ID: 37140480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles of tau protein in health and disease.
    Guo T; Noble W; Hanger DP
    Acta Neuropathol; 2017 May; 133(5):665-704. PubMed ID: 28386764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.